Å. Petersén

Transthyretin as a potential CSF biomarker for Alzheimer’s disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors

C. Nilsson, B. B. Andersen, J. Nielsen, 2010, European journal of neurology.

SIRT1 is increased in affected brain regions and hypothalamic metabolic pathways are altered in Huntington disease

G. Halliday, E. Englund, D. Kirik, 2018, Neuropathology and applied neurobiology.

Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity

P. Sundgren, J. Lätt, I. Björkman-Burtscher, 2018, International Journal of Obesity.

Brain white matter lesions are associated with reduced hypothalamic volume and cranial radiotherapy in childhood‐onset craniopharyngioma

D. van Westen, L. Rylander, E. Erfurth, 2020, Clinical endocrinology.

A23 Changes in key hypothalamic neuropeptide populations in Huntington's Disease revealed by neuropathological analyses

D. Kirik, E. McCusker, S. Gabery, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Microstructural white matter alterations and hippocampal volumes are associated with cognitive deficits in craniopharyngioma

P. Sundgren, J. Lätt, D. van Westen, 2018, European journal of endocrinology.